Skip to main content

Advertisement

Table 1 Characteristics of the total cohort also split by ISAR and CGA results

From: Health outcome of older hospitalized patients in internal medicine environments evaluated by Identification of Seniors at Risk (ISAR) screening and geriatric assessment

  Total (n = 547) ISAR- (n = 229; 41.9%) ISAR+/CGA normal (n = 145; 26.5%) ISAR+/CGA abnormal (n = 97; 17.7%) p-value ISAR+/CGA normal vs ISAR- p-value ISAR+/CGA abnormal vs ISAR- p-value ISAR+/CGA abnormal vs ISAR+/CGA normal
Age (years) 78.1 ± 6.0 77.9 ± 5.4 77.0 ± 5.9 80.5 ± 6.5 0.259 0.001 <0.001
Sex (male) 299 (54.7) 122 (53.3) 96 (66.2) 43 (44.3) 0.013 0.118 <0.001
Anemia 152 (27.8) 55 (24.0) 51 (35.2) 29 (29.9) 0.019 0.336 0.318
Chronic kidney disease 240 (43.9) 86 (37.6) 75 (51.7) 43 (44.3) 0.007 0.327 0.194
Heart failure 106 (19.4) 39 (17.0) 35 (24.1) 16 (16.5) 0.140 0.999 0.263
Coronary heart disease 213 (38.9) 90 (39.3) 51 (35.2) 45 (46.4) 0.511 0.329 0.142
Atrial fibrillation 174 (31.8) 62 (27.1) 47 (32.4) 37 (38.1) 0.293 0.050 0.412
Other cardiac arrhythmias 70 (12.8) 23 (10.0) 18 (12.4) 17 (17.5) 0.498 0.097 0.354
Valve insufficiency 196 (35.8) 78 (34.1) 53 (36.6) 39 (40.2) 0.738 0.213 0.423
Chronic obstructive pulmonary disease 69 (12.6) 25 (10.9) 17 (11.7) 15 (15.5) 0.867 0.277 0.448
Peripheral artery disease 76 (13.9) 27 (11.8) 22 (15.2) 21 (21.6) 0.348 0.040 0.237
Arterial hypertension 430 (78.6) 175 (76.4) 113 (77.9) 80 (82.5) 0.704 0.311 0.626
Diabetes 171 (31.3) 71 (31.0) 45 (31.0) 33 (34.0) 0.999 0.606 0.676
Hyperlipoproteinemia 269 (49.2) 96 (41.9) 79 (54.5) 55 (56.7) 0.025 0.011 0.694
Nicotine abuse 82 (15.0) 34 (14.8) 25 (17.2) 11 (11.3) 0.561 0.484 0.202
Obesity 116 (21.2) 46 (20.1) 29 (20.0) 23 (23.7) 0.999 0.463 0.427
History of myocardial infarction 56 (10.2) 23 (10.0) 9 (6.2) 13 (13.4) 0.255 0.443 0.073
History of pulmonary embolism 11 (2.0) 2 (0.9) 4 (2.8) 3 (3.1) 0.378 0.070 0.447
History of stroke 56 (10.2) 14 (6.1) 16 (11.0) 15 (15.5) 0.116 0.006 0.255
History of thrombosis 49 (9.0) 19 (8.3) 10 (6.9) 12 (12.4) 0.695 0.306 0.179
Hyperthyroidism 24 (4.4) 15 (6.6) 1 (0.7) 5 (5.2) 0.007 0.802 0.042
Hypothyroidism 84 (15.4) 30 (13.1) 30 (20.7) 11 (11.3) 0.081 0.859 0.118
Dementia 37 (6.8) 4 (1.7) 9 (6.2) 16 (16.5) 0.067 <0.001 0.005
Alcohol abuse 19 (3.5) 6 (2.6) 7 (4.8) 2 (2.1) 0.261 0.999 0.317
Depression 30 (5.5) 9 (3.9) 5 (3.4) 7 (7.2) 0.999 0.265 0.236
Anxiety disorder 2 (0.4) 1 (0.4) 0 (0.0) 0 (0.0) 0.999 0.999 0.999
Parkinson’s disease 6 (1.1) 3 (1.3) 2 (1.4) 0 (0.0) 0.999 0.557 0.515
Polyneuropathy 40 (7.3) 13 (5.7) 10 (6.9) 14 (14.4) 0.825 0.009 0.028
Cancer 215 (39.3) 89 (38.9) 73 (50.3) 21 (21.6) 0.041 0.003 <0.001
Cataract 33 (6.0) 8 (3.5) 13 (9.0) 6 (6.2) 0.036 0.371 0.472
Presbycusis 21 (3.8) 8 (3.5) 4 (2.8) 7 (7.2) 0.773 0.161 0.128
Anal incontinence 3 (0.5) 1 (0.4) 2 (1.4) 0 (0.0) 0.562 0.999 0.515
Urinary incontinence 4 (0.7) 1 (0.4) 0 (0.0) 2 (2.1) 0.999 0.218 0.165
Pressure ulcers 24 (4.4) 1 (0.4) 4 (2.8) 14 (14.4) 0.075 <0.001 0.002
Rheumatism 24 (4.4) 11 (4.8) 5 (3.4) 4 (4.1) 0.609 0.999 0.999
  1. CGA, comprehensive geriatric assessment; ISAR, Identification of Seniors at Risk; ISAR+, positive ISAR screening (score ≥ 2); ISAR-, negative ISAR screening (score < 2); CGA abnormal, impairment of ADL plus another domain of the CGA. In 318 ISAR+ patients, 242 CGAs were performed (76 missing due to transfer, discharge, foreign-language or incompliance of patients). Boldface values were significant at p <=0.05